Ufp Technologies (UFPT) Total Non-Current Liabilities (2010 - 2026)

Ufp Technologies (UFPT) posted Total Non-Current Liabilities of $234.0 million for Q1 2026, up 2.8% on a QoQ basis from $227.7 million in Q4 2025, and down 14.32% year-over-year from $273.2 million in Q1 2025.

Ufp Technologies (UFPT) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

Ufp Technologies' Total Non-Current Liabilities history runs 16 years deep, the most recent figure standing at $234.0 million for Q1 2026.

  • Quarterly Total Non-Current Liabilities fell 14.32% year-over-year to $234.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $234.0 million (down 14.32% YoY) and the FY2025 annual result came in at $227.7 million, down 17.24% from the prior year.
  • Total Non-Current Liabilities was $234.0 million for Q1 2026 at Ufp Technologies, up from $227.7 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $298.4 million in Q3 2024 and bottomed at $98.8 million in Q1 2024.
  • A 5-year average of $182.0 million and a median of $153.1 million in 2022 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2022 — Total Non-Current Liabilities soared 529.29% — and 2023, when it plunged 34.44%.
  • Ufp Technologies' Total Non-Current Liabilities stood at $131.1 million in 2022, then slipped by 16.12% to $109.9 million in 2023, then soared by 150.2% to $275.1 million in 2024, then slipped by 17.24% to $227.7 million in 2025, then advanced by 2.8% to $234.0 million in 2026.
  • Business Quant data shows UFPT's Total Non-Current Liabilities at $234.0 million in Q1 2026, $227.7 million in Q4 2025, and $244.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 20.94 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 41.44 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 41.88 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 2.64 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 3.53 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 9.85 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 24.21 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 3.57 Bn
10 Ufp Technologies 1.82 Bn 1.80 Bn 44.36 Mn 234.05 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 234.05 Mn
Dec 31, 2025 227.68 Mn
Sep 30, 2025 244.63 Mn
Jun 30, 2025 245.00 Mn
Mar 31, 2025 273.15 Mn
Dec 31, 2024 275.09 Mn
Sep 30, 2024 298.42 Mn
Jun 30, 2024 102.46 Mn
Mar 31, 2024 98.84 Mn
Dec 31, 2023 109.95 Mn
Sep 30, 2023 112.39 Mn
Jun 30, 2023 123.12 Mn
Mar 31, 2023 131.88 Mn
Dec 31, 2022 131.08 Mn
Sep 30, 2022 153.08 Mn
Jun 30, 2022 187.79 Mn
Mar 31, 2022 144.71 Mn
Dec 31, 2021 134.50 Mn
Sep 30, 2021 28.86 Mn
Jun 30, 2021 29.84 Mn